Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P12830: Variant p.Ser838Gly

Cadherin-1
Gene: CDH1
Feedback?
Variant information Variant position: help 838 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Serine (S) to Glycine (G) at position 838 (S838G, p.Ser838Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In an ovarian carcinoma sample; somatic mutation; loss of heterozygosity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 838 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 882 The length of the canonical sequence.
Location on the sequence: help ADTDPTAPPYDSLLVFDYEG S GSEAASLSSLNSSESDKDQD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         ADTDPTAPPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQD

                              ADTDPTAPPYDSLLVFDYEGSGSEAASLSSLNSSESDQDQD

Mouse                         ADSDPTAPPYDSLLVFDYEGSGSEAASLSSLNSSESDQDQD

Rat                           ADSDPTAPPYDSLLVFDYEGSGSEAASLSSLNSSESDQDQD

Bovine                        ADSDPTAPPYDSLLVFDYEGSGSEAATLSSLNSSESDQDQD

Chicken                       ADTDPTAPPYDSLLVFDYEGGGSEATSLSSLNSSASDQDQD

Xenopus laevis                ADNDPTAPPYDSLLVFDYEGSGSEAASLSSLNSPNSDLDQD

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 155 – 882 Cadherin-1
Chain 701 – 882 E-Cad/CTF1
Chain 732 – 882 E-Cad/CTF2
Chain 751 – 882 E-Cad/CTF3
Topological domain 731 – 882 Cytoplasmic
Region 811 – 882 Required for binding alpha, beta and gamma catenins
Modified residue 838 – 838 Phosphoserine
Modified residue 840 – 840 Phosphoserine
Modified residue 846 – 846 Phosphoserine



Literature citations
Mutations of the E-cadherin gene in human gynecologic cancers.
Risinger J.I.; Berchuck A.; Kohler M.F.; Boyd J.;
Nat. Genet. 7:98-102(1994)
Cited for: VARIANTS THR-617 AND VAL-711; VARIANT OVARIAN CANCER GLY-838;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.